Vaccines Market, By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated & Subunit Vaccines, and Live Attenuated Vaccines), By Type, By Disease Indication, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Vaccines Market size was valued at USD 78,101.20 Million in 2024, expanding at a CAGR of 5.01% from 2024 to 2032.
Vaccines are biological preparations that provide immunity against specific infectious diseases. They usually contain weakened or inactivated forms of pathogens, or fragments such as proteins or genetic material, which stimulate the immune system to recognize and fight the disease-causing organism. When exposed to the actual pathogen, the immune system is able to respond more rapidly and effectively, preventing illness. Vaccines play a crucial role in public health by reducing the spread of infectious diseases, preventing outbreaks, and protecting both individuals and communities from harmful infections. Common examples include vaccines for measles, influenza, and COVID-19.
Vaccines Market- Market Dynamics
Rising Awareness of Preventive Healthcare
The growing emphasis on preventive healthcare is a key driver of the vaccine market. As individuals and healthcare providers increasingly prioritize proactive health management, the demand for vaccines to prevent infectious diseases continues to rise. Public health campaigns, media outreach, and educational initiatives have significantly increased awareness of the critical role vaccines play in preventing serious illnesses and controlling the spread of pandemics. Furthermore, heightened focus on areas such as chronic disease prevention, maternal and child health, and global health security is fueling market growth. As vaccination becomes a higher priority across populations, the vaccine market is experiencing steady expansion across diverse regions.
Globally, governments are actively supporting vaccination efforts to enhance public health and prevent disease outbreaks. For instance, the World Health Organization (WHO) and UNICEF reported that in 2023, approximately 108 million children received three doses of the diphtheria, tetanus, and pertussis (DTP) vaccine, a key indicator of immunization coverage. However, the number of children who did not receive a single dose of the vaccine increased from 13.9 million in 2022 to 14.5 million in 2023, highlighting the need for continued efforts to reach underserved populations. Additionally, the Global Alliance for Vaccines and Immunisation (Gavi) raised $8.8 billion in funding for the 2021–2025 period, aiming to immunize 300 million more children in lower-income countries by the end of 2025 . These initiatives reflect a global commitment to improving access to vaccines and strengthening immunization systems worldwide.
Vaccines Market- Segmentation Analysis:
The global Vaccines Market is divided into six categories: Technology, Type, Disease Indication, Route of Administration, End User and Region.
The vaccine market is segmented by technology into various categories, including conjugate vaccines, recombinant vaccines, inactivated and subunit vaccines, live attenuated vaccines, toxoid vaccines, viral vector vaccines, mRNA vaccines, and other innovative vaccine types. Each technology plays a distinct role in stimulating immune responses. Conjugate vaccines link polysaccharides to proteins for stronger immunity, while recombinant vaccines use genetically engineered components to provoke an immune defense. Inactivated and subunit vaccines contain either killed pathogens or fragments thereof, and live attenuated vaccines use weakened forms of the pathogen. Toxoid vaccines target the toxins produced by bacteria rather than the bacteria themselves. Viral vector vaccines use a modified virus to deliver genetic material into cells, and mRNA vaccines use synthetic messenger RNA to instruct cells to produce antigens and trigger immunity. Among these, mRNA vaccines have emerged as the dominant technology, particularly following their unprecedented success during the COVID-19 pandemic. Their advantages—such as rapid development, high efficacy, and adaptability—have transformed the vaccine landscape. According to the U.S. Centers for Disease Control and Prevention (CDC), mRNA COVID-19 vaccines accounted for over 90% of all doses administered in the United States during the height of the pandemic, underlining their pivotal role in modern immunization efforts.
The vaccine market is also divided by type into monovalent and multivalent vaccines. Monovalent vaccines are developed to provide immunity against a single strain of a microorganism, offering targeted protection. A prominent example is the Hepatitis B vaccine, which focuses on one specific virus. These vaccines are particularly effective in regions where a single pathogen predominates. In contrast, multivalent vaccines immunize against multiple strains or diseases with one injection, enhancing coverage while minimizing the number of doses required. Examples include the MMR (measles, mumps, rubella) and DTaP (diphtheria, tetanus, pertussis) vaccines, which are staples in childhood immunization programs. Multivalent vaccines dominate the market due to their convenience, cost-effectiveness, and improved compliance, especially in national immunization campaigns. Data from the World Health Organization (WHO) shows that over 85% of children globally received DTP3 (the third dose of DTaP) by the end of 2023, highlighting the widespread adoption and public health impact of multivalent vaccine strategies.
Vaccines Market- Geographical Insights
The global vaccines market is geographically segmented across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with each region contributing based on factors such as healthcare infrastructure, government policies, and market demand.
North America holds a leading position in the global vaccines market, driven by its advanced healthcare infrastructure, high public awareness about vaccination, and the strong presence of major pharmaceutical companies such as Pfizer, Moderna, and Johnson & Johnson. The United States, in particular, leads the region with significant investments in vaccine research, development, and distribution. Government-led initiatives, including routine immunization programs and comprehensive pandemic preparedness strategies, further bolster market growth. High per capita healthcare spending and widespread access to advanced vaccine technologies enhance the region’s dominance. Ongoing innovation, regulatory support, and rapid emergency response capabilities continue to reinforce North America\'s leadership in the global vaccine market.
Asia Pacific is rapidly emerging as a key growth region in the vaccines market, fueled by large population sizes, increasing healthcare awareness, and the expansion of national immunization programs. Countries such as China, India, and Japan are making substantial investments in vaccine research, development, and domestic manufacturing. Government-backed initiatives, including universal vaccination campaigns and collaborations with global health organizations like Gavi and the WHO, are improving vaccine accessibility across the region. Additionally, local biotechnology companies are entering the market with cost-effective and innovative solutions. With improving healthcare infrastructure, rising incidences of infectious diseases, and growing export capabilities, Asia Pacific is establishing itself as a major force in the global vaccine market.
Vaccines Market- Competitive Landscape:
The vaccines market is highly competitive, shaped by the presence of established pharmaceutical leaders and innovative biotech firms striving for global impact. Major players such as GSK plc, Merck & Co., Inc., Pfizer Inc., Sanofi, CSL, and Johnson & Johnson Services, Inc. dominate the industry with broad vaccine portfolios, expansive distribution networks, and sustained investments in research and development aimed at enhancing vaccine efficacy and safety. Emerging manufacturers like Serum Institute of India Pvt. Ltd., Bharat Biotech, and Sinovac have achieved global prominence through high-volume production capabilities and strategic international collaborations. Meanwhile, new entrants such as Inovio Pharmaceuticals and Valneva SE are gaining attention by developing next-generation vaccines using novel platforms, including DNA-based and vector-based technologies.
The market remains dynamic, with ongoing mergers, acquisitions, global expansions, and collaborative research initiatives constantly reshaping the competitive landscape.
Recent Development:
- In May 2025, GSK and Pfizer reached a settlement in a global patent dispute concerning their respective respiratory syncytial virus (RSV) vaccines, Arexvy (GSK) and Abrysvo (Pfizer). GSK had accused Pfizer of infringing on patents related to Arexvy. As part of the agreement, Pfizer received a global license to use certain GSK patents and will pay royalties on sales of Abrysvo. This settlement concludes all ongoing litigation between the companies across multiple countries, resolving a key legal conflict in the RSV vaccine segment.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GSK Plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- CSL
- Emergent
- Johnson & Johnson Services, Inc.
- Astrazeneca
- Serum Institute Of India Pvt., Ltd.
- Bavarian Nordic
- Mitsubishi Tanabe Pharma Corporation
- Daiichi Sankyo Company, Limited
- Panacea Biotec
- Biological E Limited
- Bharat Biotech
- Inovio Pharmaceuticals
- Sinovac
- Incepta Pharmaceuticals Ltd.
- Valneva Se
- Vbi Vaccine Inc.
- Bio Farma
- Microgen
- Zhi Fei Biological
- Indian Immunologicals Limited
- Others
GLOBAL VACCINES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated & Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
- Mrna Vaccines
- Other Vaccines
GLOBAL VACCINES MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Multivalent Vaccines
- Monovalent Vaccines
GLOBAL VACCINES MARKET, BY DISEASE INDICATION - MARKET ANALYSIS, 2019 - 2032
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- Hpv
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- Mmr
- Varicella
- Hepatitis
- Dtp
- Polio
- Rsv
- Other Disease Indications
GLOBAL VACCINES MARKET, BY ROUTE OF ADMINISTRATION - MARKET ANALYSIS, 2019 - 2032
- Intramuscular & Subcutaneous Administration
- Oral Administration
GLOBAL VACCINES MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Adult Vaccines
- Pediatric Vaccines
GLOBAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Vaccines Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Vaccines Market Snippet by Technology
2.1.2. Vaccines Market Snippet by Type
2.1.3. Vaccines Market Snippet by Disease Indication
2.1.4. Vaccines Market Snippet by Route of Administration
2.1.5. Vaccines Market Snippet by End User
2.1.6. Vaccines Market Snippet by Country
2.1.7. Vaccines Market Snippet by Region
2.2. Competitive Insights
3. Network Attached Storage Key Market Trends
3.1. Vaccines Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Vaccines Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Vaccines Market Opportunities
3.4. Vaccines Market Future Trends
4. Network Attached Storage End User Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Vaccines Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Vaccines Market Landscape
6.1. Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Vaccines Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
7.1.2. Conjugate Vaccines
7.1.3. Recombinant Vaccines
7.1.4. Inactivated & Subunit Vaccines
7.1.5. Live Attenuated Vaccines
7.1.6. Toxoid Vaccines
7.1.7. Viral Vector Vaccines
7.1.8. MRNA Vaccines
7.1.9. Other Vaccines
8. Vaccines Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
8.1.2. Multivalent Vaccines
8.1.3. Monovalent Vaccines
9. Vaccines Market – By Disease Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
9.1.2. Pneumococcal Disease
9.1.3. Influenza
9.1.4. Combination Vaccines
9.1.5. Hpv
9.1.6. Meningococcal Disease
9.1.7. Herpes Zoster
9.1.8. Rotavirus
9.1.9. Mmr
9.1.10. Varicella
9.1.11. Hepatitis
9.1.12. Dtp
9.1.13. Polio
9.1.14. Rsv
9.1.15. Other Disease Indications
10. Vaccines Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
10.1.2. Intramuscular & Subcutaneous Administration
10.1.3. Oral Administration
11. Vaccines Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
11.1.2. Adult Vaccines
11.1.3. Pediatric Vaccines
12. Vaccines Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Network Attached Storage Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Network Attached Storage Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Network Attached Storage Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Network Attached Storage Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Network Attached Storage Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Network Attached Storage End User
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. GSK Plc
13.2.2. Merck & Co., Inc.
13.2.3. Pfizer Inc.
13.2.4. Sanofi
13.2.5. CSL
13.2.6. Emergent
13.2.7. Johnson & Johnson Services, Inc.
13.2.8. Astrazeneca
13.2.9. Serum Institute Of India Pvt. Ltd.
13.2.10. Bavarian Nordic
13.2.11. Mitsubishi Tanabe Pharma Corporation
13.2.12. Daiichi Sankyo Company, Limited
13.2.13. Panacea Biotec
13.2.14. Biological E Limited
13.2.15. Bharat Biotech
13.2.16. Inovio Pharmaceuticals
13.2.17. Sinovac
13.2.18. Incepta Pharmaceuticals Ltd.
13.2.19. Valneva Se
13.2.20. Vbi Vaccine Inc.
13.2.21. Bio Farma
13.2.22. Microgen
13.2.23. Zhi Fei Biological
13.2.24. Indian Immunologicals Limited
13.2.25. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
